How to Develop a Comprehensive Strategy for the Analysis of Transcription Factors
Toll Free 1-877-266-8388 Tel: 1-408-747-0771
Fax: 1-408-470-7719
Quick Lead Time | Global Overnight Delivery Available
Purchase Order: info@signosisinc.com
How Innovative Methods for Cytokine Quantification Advance our Understanding of Human Health and Disease
How Stable Reporter Cell Lines Advance Therapeutic Target Discovery and Compound Screening
Fisher Scientific Utilizes Signosis' Stable Cell Lines for High-Throughput Screening Assay Kit
Pfizer's TicoVac™ achieves FDA Priority Review with the help of Signosis' Rat Inflammation ELISA
Johnson & Johnson Leverages Signosis' Stable Cell Lines for U.S. FDA EGFR Drug Development
Signosis' Luciferase Reporter Cell Lines and Johnson & Johnson's mRNA COVID-19 Vaccine Development
Signosis and Stratech Join Forces to Develop Advanced Tools for Studying Chemokines and Inflammation
Stanford Medicine Advances Molecular Biology with TF Activation Profiling Plate Array
Signosis Empowers National Institute of Health's Study on Identifying Functional Variants at Disease
Harvard Medicine's Study on TF Programming Landscape in hPSCs Utilizes Signosis' Comprehensive Array
Genentech's Study on the Peroxisomal Targeting Signal in Firefly Luciferase Reveals New Insights
Genentech Successfully Develops Monoclonal Antibody Production Using Signosis' Luciferase Line
What is the role of transcription factors in tumorigenesis and cancer treatment?
How do transfected stable cell lines advance biomedical research?